// App-Quantinova.ai

BSH19‐EP‐046 : Infusion related reactions (IRRs) and early toxicities of Daratumumab: Single centre experience

Researchers

Presenter

  • S. Munireddy

Principal Investigators

  • A. Mukherjee

  • G. Asagba

  • T. Chatzis

  • L. Barton

  • M. Garg

  • R. Krishna

Medical Centers

  • Department of Rheumatology, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Autoimmune (AI)

  • Blood/haematological Diseases

  • Infectious Diseases (ID)

  • Peripheral Nervous System

  • Oncology (ONC)

Disease

  • Peripheral neuropathy

  • Allergic rhinitis

  • Multiple Myeloma

  • Thrombocytopenia

  • Asthma

  • Hypertension

  • Anaphylaxis

  • Neutropenia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • daratumumab Intravenous

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved